In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Brain Tissue Oxygenation and 3 and 6-month Neurological Outcome in Severe Traumatic Brain Injury

    Final Number:
    163

    Authors:
    David Michael Panczykowski MD; Ava Puccio RN; Yue-Fang Chang PhD; Lori Shutter MD; David O. Okonkwo MD, PhD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2014 Annual Meeting

    Introduction: Brain tissue oxygenation (PbtO2) monitoring has been utilized in the severe traumatic brain injury (sTBI) population as an in vivo tool to detect oxygenation changes in the acute injury phase. It has been previously reported that the longer a patient experiences a PbtO2 of = 15 torr, the greater the likelihood of death. The purpose of this study is to assess PbtO2values and its relationship to 3 and 6-month outcome in adult sTBI.

    Methods: Under an approved IRB protocol, PbtO2 data were prospectively collected on sTBI patients ( Glasgow Coma Scale (GCS) score <9) during the acute 5 days following injury. ICU management included ICP management per Guidelines of sTBI Management; however, PbtO2 was not treated, just monitored. Glasgow Outcome Scale (GOS) score, a measurement of neurologic outcome, was assessed at 3 and 6-months from injury and dicotomized into poor (GOS 1-3) and favorable outcome (GOS 4-5). Statistical analyses were performed using a logistic regression model controlling for age and initial severity of injury.

    Results: 258 adult, sTBI patients with 3 and 6-month outcome were included. The mean age was 38±17 years, with 69% male and a median GCS of 6. Post-trauma day (PTD) 2 PbtO2 data was chosen for analysis to avoid insertional microtrauma and minimize variability of values seen within the first 24 hours of monitoring. Logistic regression resulted in cut-off values of minimum PbtO2 < 16.03 and maximum PbtO2 > 37.15 being significant for poor 3-month neurological outcome (OR 2.46, 95%CI 1.29-4.68 p=.004 & OR 2.71, 95%CI 1.37-5.33 p=.006 repectively). There was no residual significance for 6-month neurological outcome at these same cutoffs; however, PTD2 PbtO2 values in combination for minimum <18.3 and maximum >37.2 were significant predictors of poor outcome (OR 2.02, 95%CI 1.11-3.67, p=.02).

    Conclusions: Monitoring of PbtO2 in the adult sTBI population may be predictive of 3 month neurological outcome and provide a target cohort for early rehabilitation efforts. Additional studies are needed to assess the effectiveness of treating PbtO2 values.

    Patient Care: The use of brain tissue oxygenation as a neuromonitoring, goal-directed end-point may help achieve better 3- and 6-month outcomes following traumatic brain injury.

    Learning Objectives: To understand the utility of Brain tissue oxygenation to predict 3- and 6-month outcome.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy